Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1985 March; 75(3): 809–817.
PMCID: PMC423608

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.


Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension. A review. Circulation. 1969 Mar;39(3):403–421. [PubMed]
  • Bray GA. Obesity. Dis Mon. 1979 Oct;26(1):1–85. [PubMed]
  • Medalie JH, Papier CM, Goldbourt U, Herman JB. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med. 1975 Jun;135(6):811–817. [PubMed]
  • Zimmet P. Type 2 (non-insulin-dependent) diabetes--an epidemiological overview. Diabetologia. 1982 Jun;22(6):399–411. [PubMed]
  • Barret-Connor E, Criqui MH, Klauber MR, Holdbrook M. Diabetes and hypertension in a community of older adults. Am J Epidemiol. 1981 Mar;113(3):276–284. [PubMed]
  • Jarrett RJ, Keen H, McCartney M, Fuller JH, Hamilton PJ, Reid DD, Rose G. Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol. 1978 Mar;7(1):15–24. [PubMed]
  • Butler WJ, Ostrander LD, Jr, Carman WJ, Lamphiear DE. Diabetes mellitus in Tecumseh, Michigan. Prevalence, incidence, and associated conditions. Am J Epidemiol. 1982 Dec;116(6):971–980. [PubMed]
  • Reaven GM. Insulin-independent diabetes mellitus: metabolic characteristics. Metabolism. 1980 May;29(5):445–454. [PubMed]
  • Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol. 1982 Jul;243(1):E15–E30. [PubMed]
  • DeFronzo RA, Ferrannini E. The pathogenesis of non-insulin-dependent diabetes: an update. Medicine (Baltimore) 1982 May;61(3):125–140. [PubMed]
  • Grunberger G, Taylor SI, Dons RF, Gorden P. Insulin receptors in normal and disease states. Clin Endocrinol Metab. 1983 Mar;12(1):191–219. [PubMed]
  • Flier JS. Insulin receptors and insulin resistance. Annu Rev Med. 1983;34:145–160. [PubMed]
  • DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981 Sep;21(3):165–171. [PubMed]
  • Clegg G, Morgan DB, Davidson C. The heterogeneity of essential hypertension. Relation between lithium efflux and sodium content of erythrocytes and a family history of hypertension. Lancet. 1982 Oct 23;2(8304):891–894. [PubMed]
  • Cole CH. Erythrocyte membrane sodium transport in patients with treated and untreated essential hypertension. Circulation. 1983 Jul;68(1):17–22. [PubMed]
  • De Luise M, Blackburn GL, Flier JS. Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med. 1980 Oct 30;303(18):1017–1022. [PubMed]
  • Klimes I, Nagulesparan M, Unger RH, Aronoff SL, Mott DM. Reduced Na+, K+ -ATPase activity in intact red cells and isolated membranes from obese man. J Clin Endocrinol Metab. 1982 Apr;54(4):721–724. [PubMed]
  • Trevisan M, Ostrow D, Cooper R, Liu K, Sparks S, Okonek A, Stevens E, Marquardt J, Stamler J. Abnormal red blood cell ion transport and hypertension. The People's Gas Company study. Hypertension. 1983 May-Jun;5(3):363–367. [PubMed]
  • Moore RD. Effects of insulin upon ion transport. Biochim Biophys Acta. 1983 Mar 21;737(1):1–49. [PubMed]
  • Cox M, Sterns RH, Singer I. The defense against hyperkalemia: the roles of insulin and aldosterone. N Engl J Med. 1978 Sep 7;299(10):525–532. [PubMed]
  • Friedman SM. Monovalent and divalent ions in vascular tissue. Ann Intern Med. 1983 May;98(5 Pt 2):753–757. [PubMed]
  • Resh MD. Development of insulin responsiveness of the glucose transporter and the (Na+,K+)-adenosine triphosphatase during in vitro adipocyte differentiation. J Biol Chem. 1982 Jun 25;257(12):6978–6986. [PubMed]
  • Modan M, Halkin H, Karasik A, Lusky A. Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol. 1984 Mar;119(3):431–444. [PubMed]
  • DeFronzo RA. Glucose intolerance and aging. Diabetes Care. 1981 Jul-Aug;4(4):493–501. [PubMed]
  • Fink RI, Kolterman OG, Griffin J, Olefsky JM. Mechanisms of insulin resistance in aging. J Clin Invest. 1983 Jun;71(6):1523–1535. [PMC free article] [PubMed]
  • Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet. 1982 Dec 11;2(8311):1293–1295. [PubMed]
  • Cerasi E, Ependić S, Luft R. Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet. 1973 Apr 14;1(7807):794–797. [PubMed]
  • Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. [PubMed]
  • Flamenbaum W. Metabolic consequences of antihypertensive therapy. Ann Intern Med. 1983 May;98(5 Pt 2):875–880. [PubMed]
  • Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study. Am J Epidemiol. 1981 Nov;114(5):697–704. [PubMed]
  • Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966 Jun 18;1(7451):1336–1337. [PubMed]
  • Berglund G, Andersson O. Body composition, metabolic and hormonal characteristics in unselected male hypertensives. Int J Obes. 1981;5 Suppl 1:143–150. [PubMed]
  • Voors AW, Radhakrishnamurthy B, Srinivasan SR, Webber LS, Berenson GS. Plasma glucose level related to blood pressure in 272 children, ages 7-15 years, sampled from a total biracial population. Am J Epidemiol. 1981 Apr;113(4):347–356. [PubMed]
  • Florey CV, Uppal S, Lowy C. Relation between blood pressure, weight, and plasma sugar and serum insulin levels in schoolchildren aged 9-12 years in Westland, Holland. Br Med J. 1976 Jun 5;1(6022):1368–1371. [PMC free article] [PubMed]
  • CRAIG AB, Jr, MENDELL PL. Blockade of hyperkalemia and hyperglycemia induced by epinephrine in frog liver and in cats. Am J Physiol. 1959 Jul;197(1):52–54. [PubMed]
  • DeFronzo RA, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol. 1980 May;238(5):E421–E427. [PubMed]
  • DeFronzo RA, Sherwin RS, Dillingham M, Hendler R, Tamborlane WV, Felig P. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings. J Clin Invest. 1978 Feb;61(2):472–479. [PMC free article] [PubMed]
  • McNair P, Madsbad S, Christiansen C, Christensen MS, Transbøl I. Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. Clin Chim Acta. 1982 Apr 8;120(2):243–250. [PubMed]
  • Porter GA. Chronology of the sodium hypothesis and hypertension. Ann Intern Med. 1983 May;98(5 Pt 2):720–723. [PubMed]
  • Tobian L. Human essential hypertension: implications of animal studies. Ann Intern Med. 1983 May;98(5 Pt 2):729–734. [PubMed]
  • MacGregor GA. Dietary sodium and potassium intake and blood pressure. Lancet. 1983 Apr 2;1(8327):750–753. [PubMed]
  • Laragh JH, Pecker MS. Dietary sodium and essential hypertension: some myths, hopes, and truths. Ann Intern Med. 1983 May;98(5 Pt 2):735–743. [PubMed]
  • Winquist RJ, Webb RC, Bohr DF. Vascular smooth muscle in hypertension. Fed Proc. 1982 Jun;41(8):2387–2393. [PubMed]
  • Christensen NJ. Acute effects of insulin on cardiovascular function and noradrenaline uptake and release. Diabetologia. 1983 Nov;25(5):377–381. [PubMed]
  • Epstein FH, Rosa RM. Adrenergic control of serum potassium. N Engl J Med. 1983 Dec 8;309(23):1450–1451. [PubMed]
  • Jenkins DJ, Taylor RH, Wolever TM. The diabetic diet, dietary carbohydrate and differences in digestibility. Diabetologia. 1982 Dec;23(6):477–484. [PubMed]
  • Halverson JD, Kramer J, Cave A, Permutt A, Santiago J. Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery. 1982 Aug;92(2):235–240. [PubMed]
  • Lohmann D, Liebold F, Heilmann W, Senger H, Pohl A. Diminished insulin response in highly trained athletes. Metabolism. 1978 May;27(5):521–524. [PubMed]
  • LeBlanc J, Nadeau A, Boulay M, Rousseau-Migneron S. Effects of physical training and adiposity on glucose metabolism and 125I-insulin binding. J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):235–239. [PubMed]
  • Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978 Jan 5;298(1):1–6. [PubMed]
  • Hovell MF. The experimental evidence for weight-loss treatment of essential hypertension: a critical review. Am J Public Health. 1982 Apr;72(4):359–368. [PubMed]
  • Paffenbarger RS, Jr, Wing AL, Hyde RT, Jung DL. Physical activity and incidence of hypertension in college alumni. Am J Epidemiol. 1983 Mar;117(3):245–257. [PubMed]
  • Puska P, Iacono JM, Nissinen A, Korhonen HJ, Vartianinen E, Pietinen P, Dougherty R, Leino U, Mutanen M, Moisio S, et al. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983 Jan 1;1(8314-5):1–5. [PubMed]
  • Fehily AM, Milbank JE, Yarnell JW, Hayes TM, Kubiki AJ, Eastham RD. Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure. Am J Clin Nutr. 1982 Nov;36(5):890–896. [PubMed]
  • Glass AR, Bongiovanni R, Smith CE, Boehm TM. Normal valine disposal in obese subjects with impaired glucose disposal: evidence for selective insulin resistance. Metabolism. 1981 Jun;30(6):578–582. [PubMed]
  • Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980 Jun 28;1(8183):1373–1376. [PubMed]
  • Pyöräla K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979 Mar-Apr;2(2):131–141. [PubMed]
  • Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980 Sep;19(3):205–210. [PubMed]
  • Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979 Mar-Apr;2(2):154–160. [PubMed]
  • Stamler J. George Lyman Duff Memorial Lecture. Lifestyles, major risk factors, proof and public policy. Circulation. 1978 Jul;58(1):3–19. [PubMed]
  • Ashley FW, Jr, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis. 1974 Mar;27(3):103–114. [PubMed]
  • Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J. 1977 Nov 19;2(6098):1307–1314. [PMC free article] [PubMed]
  • Burr ML, Sweetnam PM. Vegetarianism, dietary fiber, and mortality. Am J Clin Nutr. 1982 Nov;36(5):873–877. [PubMed]
  • Paffenbarger RS, Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978 Sep;108(3):161–175. [PubMed]
  • Morris JN, Everitt MG, Pollard R, Chave SP, Semmence AM. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet. 1980 Dec 6;2(8206):1207–1210. [PubMed]
  • Stout RW. Is insulin atherogenic? Mt Sinai J Med. 1982 May-Jun;49(3):223–226. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation